New Serotonin 5-HT<sub>1A</sub> Receptor Agonists with Neuroprotective Effect against Ischemic Cell Damage

Isabel Marco, Margarita Valhondo, Mar Martín‐Fontecha, Henar Vázquez‐Villa, Anna M. Planas, Onintza Sagredo, José A. Ramos, Iván R. Torrecillas, Leonardo Pardo, Diana Frechilla,

Journal of Medicinal Chemistry · 2011 · 44 citations · 51 references

DOIFull text

Open access

Concepts

Abstract

We report the synthesis of new compounds 4-35 based on structural modifications of different moieties of previously described lead UCM-2550. The new nonpiperazine derivatives, representing second-generation agonists, were assessed for binding affinity, selectivity, and functional activity at the 5-HT(1A) receptor (5-HT(1A)R). Computational β(2)-based homology models of the ligand-receptor complexes were used to explain the observed structure-affinity relationships. Selected candidates were also evaluated for their potential in vitro and in vivo neuroprotective properties. Interestingly, compound 26 (2-{6-[(3,4-dihydro-2H-chromen-2-ylmethyl)amino]hexyl}tetrahydro-1H-pyrrolo[1,2-c]imidazole-1,3(2H)-dione) has been characterized as a high-affinity and potent 5-HT(1A)R agonist (K(i) = 5.9 nM, EC(50) = 21.8 nM) and exhibits neuroprotective effect in neurotoxicity assays in primary cell cultures from rat hippocampus and in the MCAO model of focal cerebral ischemia in rats.

References

51